Tag Archives: FDA

Sigh And Bye Asterias

Posted on November 16, 2018 by Tom Trimbath

Rats. It happened again. A corporation agreed with me. A company with great potential and an undervalued stock can be a great investment. In the case of Asterias, that meant BioTime is buying the entire company. Yet again, one of … Continue reading →

Posted in Uncategorized | Tagged , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

GERN Spikes I Buy AST

Posted on March 22, 2018 by Tom Trimbath

Here’s a happy chart for a long term investor. In less than an hour and a half, stock in one of my oldest positions rose from ~$5 to over $6.60. Over 30% rise in under 90 minutes. Extrapolate that out … Continue reading →

Posted in Uncategorized | Tagged , , , , , , , , , , | Leave a comment

Asterias May Have One Success

Posted on September 8, 2016 by Tom Trimbath

One of my smaller investments had good news. It appears they’ve been able to regrow severed nerves. One of their trial patients has regained use of his arms. Amidst the cautions layered around investments and health care news it was … Continue reading →

Posted in Uncategorized | Tagged , , , , , , , , , , , | 2 Comments

Wealth Through Health

Posted on November 9, 2013 by Tom Trimbath

Yes, it is possible to hear good news from the biotech community. The problem is understanding what they say, why they’re saying it, and what they’re not saying. Geron (GERN) had some great news. Pardon me as I look up … Continue reading →

Posted in Uncategorized | Tagged , , , , , , , , , , , , , , , , , , , | 2 Comments